Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation

Br J Dermatol. 2023 Apr 20;188(5):586-590. doi: 10.1093/bjd/ljad014.

Authors

Mario Valenti^{1

2}, Antonio Costanzo^{1

2}

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
² Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.

PMID: 36655398
DOI: 10.1093/bjd/ljad014

No abstract available

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Communication
Cross-Sectional Studies
Humans
Pandemics / prevention & control
Psoriasis*